In re: Bayer Corporation Combination Aspirin Products Marketing and Sales Practices Litigation

February 5, 2013

Victories

admin

Photo credit: Wikimedia

Docket number: No. 09-md-2023 (BMC) (JMA), (E.D.N.Y. Apr. 11, 2013)

As a result of the Center’s objection, the parties modified the settlement to increase direct payments to the class by over $5.8M. Our second objection resulted in a third-party recipient of settlement funds that better suited the purpose of the litigation.

Case Documents

Description
Apr 11, 2013 ORDER of the District Court

 

TAGS:

Bayer Litigation

TAKE A MINUTE AND SHARE

HLLI In The News

Search this website Type then hit enter to search